MODERN Labeling Act of 2020

Summary

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020 This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

10 official files

• Referred in Senate (text)

  Referred in Senate · EN · 18 November 2020

  ViewDownloadOpen at official source

• Referred in Senate (PDF)

  Referred in Senate · EN · 18 November 2020

  ViewDownloadOpen at official source

• Engrossed in House (text)

  Engrossed in House · EN · 17 November 2020

  ViewDownloadOpen at official source

• Engrossed in House (PDF)

  Engrossed in House · EN · 17 November 2020

  ViewDownloadOpen at official source

• Passed House

  summary · EN · 17 November 2020

  Open at official source

• Reported in House (text)

  Reported in House · EN · 16 November 2020

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 16 November 2020

  ViewDownloadOpen at official source

• Introduced in House (text)

  Introduced in House · EN · 24 January 2020

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 24 January 2020

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 24 January 2020

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.